Trials / Completed
CompletedNCT05875636
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 260 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Esophagogastroduodenoscopy | All patients will undergo an esophagogastroduodenoscopy per standard of care, as scheduled. |
Timeline
- Start date
- 2023-08-21
- Primary completion
- 2024-08-23
- Completion
- 2024-08-23
- First posted
- 2023-05-25
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05875636. Inclusion in this directory is not an endorsement.